Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Guselkumab dose 1's trials
ASTRO
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Guselkumab Dose 1
Ongoing
Active not recruiting
Phase 3
Open NCT05528510 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record